Analysts expect Presbia PLC (NASDAQ:LENS) to announce earnings of ($0.26) per share for the current quarter, Zacks reports. Zero analysts have provided estimates for Presbia’s earnings. Presbia posted earnings of ($0.32) per share in the same quarter last year, which would suggest a positive year-over-year growth rate of 18.8%. The business is scheduled to report its next earnings results on Friday, November 24th.
According to Zacks, analysts expect that Presbia will report full year earnings of ($1.10) per share for the current financial year. For the next financial year, analysts forecast that the firm will report earnings of ($1.24) per share. Zacks’ EPS averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Presbia.
Several analysts recently issued reports on LENS shares. Zacks Investment Research cut Presbia from a “hold” rating to a “sell” rating in a research note on Wednesday, October 11th. Jefferies Group LLC reaffirmed a “buy” rating and set a $10.00 price objective (down from $11.00) on shares of Presbia in a research report on Friday, October 6th. Finally, ValuEngine raised Presbia from a “strong sell” rating to a “sell” rating in a research report on Friday, September 1st. Two investment analysts have rated the stock with a sell rating and three have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $11.33.
A hedge fund recently raised its stake in Presbia stock. FMR LLC lifted its stake in Presbia PLC (NASDAQ:LENS) by 0.5% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,568,278 shares of the medical instruments supplier’s stock after purchasing an additional 13,375 shares during the quarter. FMR LLC owned about 15.15% of Presbia worth $5,856,000 as of its most recent filing with the Securities & Exchange Commission. 16.50% of the stock is owned by institutional investors and hedge funds.
Shares of Presbia (LENS) opened at $3.37 on Monday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.94 and a current ratio of 3.02. Presbia has a 12 month low of $1.86 and a 12 month high of $5.88.
TRADEMARK VIOLATION WARNING: “Zacks: Brokerages Anticipate Presbia PLC (LENS) Will Post Earnings of -$0.26 Per Share” was first posted by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://transcriptdaily.com/2017/11/27/zacks-brokerages-anticipate-presbia-plc-lens-will-post-earnings-of-0-26-per-share.html.
Presbia PLC is an ophthalmic device company. The Company develops and markets an optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects. The Company’s segment is the restoration of clear vision caused by presbyopia. The Company provides the refractive lens for patient surgeries and accessories for procedures performed exclusively outside the United States.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Presbia PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Presbia PLC and related companies with MarketBeat.com's FREE daily email newsletter.